RBT-08

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRBT-08
Drug Alias NameRBT-08
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionC-type lectins modulators
TargetsC-type lectins
Therapy Area/IndicationsTesticular Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRodos BioTarget GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRodos BioTarget GmbH
Active IndicationsN/A
Inactive IndicationsTesticular Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A